Seed Grant Program

Building on the very successful Seed Grant Program in basic and early translational research, which has resulted in more than $4 million in joint research awards, the Institute for Bioscience and Biotechnology Research, a component of the University of Maryland Initiatives, has launched a new seed grant program in complex therapeutics.

Seed grant funding can be used to develop new tools—such as technologies—that improve health care. It also can be used to stimulate applications to federal and other agencies and provided the opportunity for UMCP’s Jaydev Desai, PhD, MA, MS, and UMB’s Rao Gullapalli, PhD, MBA, and J. Marc Simard, MD, PhD, to submit their application titled  “Minimally Invasive Neurosurgical Intracranial Robot” to the National Institutes of Health (NIH) for funding. In October 2012 they were awarded $2 million by the NIH to continue their collaborative research in this area.

A seed grant program to promote innovative methodologies and prototypes suitable for commercialization also is happening.

Contact the following for more information:

Bruce Jarrell, MD, FACS, Chief Academic and Research Officer, Senior Vice President, Dean, Graduate School, UMB

Patrick O’Shea, PhD, MS, Chief Research Officer, Vice President, UMCP